title: Authors' reply to Dr. Malerbi: "Insulin glargine in a Brazilian state: should the government disinvest?".
authors.affiliation: Medical College, Federal University of Minas Gerais (UFMG), Av. Antônio Carlos, 6627, Bloco 02, sl 1048, Belo Horizonte, MG, CEP 31270-901, Brazil, analuisacaires@gmail.com.
authors.forename: Ana Luísa Caires
authors.initials: AL
authors.lastname: de Souza
authors.forename: Francisco de Assis
authors.initials: Fde A
authors.lastname: Acurcio
authors.forename: Augusto Afonso
authors.initials: AA
authors.lastname: Guerra Júnior
authors.forename: Renata Cristina Rezende Macedo
authors.initials: RC
authors.lastname: do Nascimento
authors.forename: Brian
authors.initials: B
authors.lastname: Godman
authors.forename: Leonardo Maurício
authors.initials: LM
authors.lastname: Diniz
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D004341:Drug Evaluation; D006801:Humans; D007336:Insulin, Isophane / Q000191:economics*; D049528:Insulin, Long-Acting / Q000191:economics*
chemical_list: D049528:Insulin, Long-Acting; D007336:Insulin, Isophane